| Literature DB >> 18058473 |
Edgar Shiu-Lam Liu1, Yi-Ni Ye, Vivian Yvonne Shin, William Ka-Kei Wu, Benjamin Chun-Yu Wong, Chi-Hin Cho.
Abstract
The interactions of cigarette smoking with COX-2 on colitis and colitis-associated adenoma formation were studied. Mice were induced with colitis and exposed to cigarette smoke (CS) and/or SC236 (a COX-2 inhibitor). Results indicated that CS did not alter acute colonic inflammation. Addition of SC236 abolished the induction of proliferation and oxidative damage by colitis. Chronic SC236 treatment abolished the promoting effect of CS on colonic adenoma formation, via suppression of COX-2- and VEGF-mediated proliferation and angiogenesis, and reversed bcl-2-mediated inhibition of apoptosis by CS. To conclude, COX-2 inhibitor could be an implication on cancer prevention in smokers with chronic colitis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18058473 DOI: 10.1080/07357900701563897
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176